Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Make Your 2024 Wish a Reality with Save the Children 2024-01-08 12:00
Juniper Biologics Clinches Prestigious Molecular Science & Technology Acquisition of the Year Award at the Acquisition International M&A Awards 2023 2024-01-08 09:00
2024 Trend Forecast for Cosmetic Surgery & Medical Aesthetics in Singapore 2024-01-08 09:00
Suvoda Announces 30% Growth in 2023 Driven by Strong Customer Adoption of New Suvoda Platform and Products 2024-01-08 08:00
Kexing Biopharm Introduces Eribulin Mesylate Injection, Expanding Its Overseas Product Portfolio 2024-01-05 19:44
Innovations in China's Greater Bay Area: Global Pitch Competition for Startups Announces Winners 2024-01-05 18:23
Nanoform Commenced Relative Bioavailability Study of Nanotechnology-Enhanced Enzalutamide 2024-01-05 14:35
Leading New Trends & Stimulating New Vitality, HNC Shenzhen 2023 Came to a Satisfactory Close. See You in Shanghai in 2024. 2024-01-05 10:10
UniFAHS Raises USD 1.4 Million in Seed Funding to Scale Bacteriophage Technology for Sustainable Agriculture 2024-01-05 10:00
Therabody, the Global Leader In Wellness Technology, Defends Against Recent Patent Infringement Lawsuit Filed by Hyperice 2024-01-05 06:33
Greenway Health Earns Frost & Sullivan's 2023 North American Revenue Cycle Management Customer Value Leadership Award for Consistently Delivering Products and Services that Enhance Health Providers and Patients Experiences 2024-01-05 04:30
Menarini Group and Insilico Medicine Enter Global Exclusive License Agreement for Novel KAT6 Inhibitor for Potential Breast Cancer Treatment and Other Oncology Indications 2024-01-05 00:19
JW Therapeutics Announces NMPA Acceptance of the Supplemental Biological License Application for Carteyva® in Patients with Relapsed or Refractory Mantle Cell Lymphoma 2024-01-04 21:40
Avenzo Therapeutics Announces Global License of AVZO-021 (ARTS-021), a Potentially Best-in-Class Clinical Stage CDK2 Inhibitor from Allorion Therapeutics 2024-01-04 21:02
Telix to Present at the 42nd Annual J.P. Morgan Healthcare Conference 2024-01-04 06:20
Turn Biotechnologies' Expanded eTurna™ Delivery Platform Designed to Solve Delivery and Targeting Issues that Challenge Industry 2024-01-03 22:00
Mr. Chong-Yoon Lim, Chairman of COREE Group emphasizes "Creative destruction and Healthcare 4.0" [New Year Message at X-Twitter SNS] 2024-01-03 22:00
Brii Biosciences Appoints Dr. Brian Alvin Johns as Chief Scientific Officer 2024-01-03 20:00
Ribo partners with Boehringer Ingelheim to develop new treatments for people with liver diseases 2024-01-03 19:37
Belief BioMed Successfully Completed Dosing of First Subject in the Registrational Clinical Trial for Hemophilia A 2024-01-03 18:10
1 88 89 90 91 92 810